Holen Sie sich die Stockscreener-App
3.155
1.10%
-0.035
Handel nachbörslich:
3.12
-0.035
-1.11%
Schlusskurs vom Vortag:
$3.19
Offen:
$3.16
24-Stunden-Volumen:
17,588
Relative Volume:
0.15
Marktkapitalisierung:
$4.16M
Einnahmen:
$40,400
Nettoeinkommen (Verlust:
$-9.18M
KGV:
-11.75
EPS:
-0.2684
Netto-Cashflow:
$-5.78M
1W Leistung:
+13.90%
1M Leistung:
+4.82%
6M Leistung:
-89.44%
1J Leistung:
-97.23%
1-Tages-Spanne:
$3.025
$3.27
1-Wochen-Bereich:
$2.67
$3.4999
52-Wochen-Spanne:
$2.251
$135.75
Jupiter Neurosciences Inc Stock (JUNS) Company Profile
Firmenname
Jupiter Neurosciences Inc
Sektor
Branche
Telefon
(561) 406-6154
Adresse
1001 NORTH US HWY 1, JUPITER
Compare JUNS vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JUNS
Jupiter Neurosciences Inc
|
3.155 | 4.16M | 40,400 | -9.18M | -5.78M | -0.2684 |
VRTX
Vertex Pharmaceuticals Inc
|
508.74 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.35 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.50 | 53.23B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.30 | 42.34B | 5.76B | 514.49M | 1.10B | 4.4813 |
Jupiter Neurosciences Inc Aktie (JUNS) Neueste Nachrichten
Its share price met one Nasdaq rule. Jupiter Neurosciences (NASDAQ: JUNS) still faces delisting. - Stock Titan
Certain Stock Options of Jupiter Neurosciences, Inc. are subject to a Lock-Up Agreement Ending on 23-SEP-2026. - marketscreener.com
Certain Common Stock of Jupiter Neurosciences, Inc. are subject to a Lock-Up Agreement Ending on 23-SEP-2026. - marketscreener.com
Jupiter Neurosciences (Nasdaq: JUNS) lowers meeting quorum to one-third - Stock Titan
Jupiter Neurosciences, Inc. Warrants (JUNSW) Peer Comparison – Compare with Others - Value Research
Orca Capital AG Discloses 3.3% Passive Stake in Jupiter Neurosciences (NASDAQ: JUNS) - Kalkine Media
Jupiter Neurosciences (NASDAQ: JUNS) Faces Nasdaq Capital Market Delisting Over $35M Market-Value Deficiency - kalkinemedia.com
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Jupiter Neurosciences Received Notice of Delisting - tradingview.com
Jupiter Neurosciences (NASDAQ: JUNS) to appeal Nasdaq delisting - Stock Titan
Jupiter Neurosciences Faces Nasdaq Delisting Risk Despite Compliance - TipRanks
Jupiter (JUNS) Quarterly Results: The Available Earnings Metric Delivers a Beat in Latest Trading; Latest Reaction: Shares Move Lower 8.66% for the Current SessionTax Rate Impact - vinanet.vn
Jupiter Neurosciences Gains Relief from Insider Debt Forgiveness - TipRanks
Jupiter Neurosciences (JUNS) starts drawing on $20M equity line after new stock deal - Stock Titan
Jupiter Neurosciences (NASDAQ: JUNS) raises $2M as Nasdaq review continues - Stock Titan
Jupiter Neurosciences Raises $2.0 Million in Registered Direct Offering - minichart.com.sg
Jupiter Neurosciences Prices $2.0 Million Registered Direct Offering at $6.50 Per Share - TradingView
Jupiter Neurosciences Stock Surges Friday: What's Driving the Action? - Sahm
JUNS Jumps As Jupiter Neurosciences Prices Equity Deal - StocksToTrade
Jupiter Neurosciences, Inc. stock plunges 44% after spiking to $11.14 - Cryptonews.net
Jupiter Neurosciences, Inc. stock Analysis: August 2026 Volatility & Trend Review - The Cryptonomist
Best Pharmaceutical Stocks To Watch TodayAugust 21st - MarketBeat
Friday's session: most active stocks - ChartMill
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Jupiter Neurosciences Prices $2.0 Million Direct Offering - marketscreener.com
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering - The Manila Times
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering - GlobeNewswire
Jupiter Neurosciences Jumps 59% as Volume Hits 59 Times Its Share Count - TechStock²
Jupiter Neurosciences Surges as Post-Split Float Shrinks and Traders Revisit Pipeline Expansion - quiverquant.com
JUNS Stock Whipsaws As New Insider Ownership Is Disclosed - timothysykes.com
JUNS Stock Draws Focus After New Insider Ownership Filing - StocksToTrade
Jupiter Neurosciences Stock Surges Friday: What's Driving the Action? - Benzinga
JUNS Stock Jumps As New Insider Ownership Revealed - StocksToTrade
JUNS Stock Jumps As New Insider Ownership Comes To Light - timothysykes.com
Which stocks are moving before the opening bell on Friday? - ChartMill
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
JUNS Stock Whipsaws As New Insider Files Form 3 - StocksToTrade
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering - Yahoo Finance
Jupiter Neurosciences proposes selling 307,692 shares for about $2 million - Stock Titan
Jupiter (JUNS) Trading: Posts a 3.81% Loss to $4.80 on the Day; Immediate View: the $4.56 to $5.04 Range Remains in Focus in the Current UpdateEase of Movement - vinanet.vn
Andrew Jon Cutler Net Worth (2026) - GuruFocus
Real Parkinson’s Disease Hope from Jupiter Neurosciences - Yahoo Finance
Jupiter Neurosciences, Inc. announced that it has received $0.774787 million in funding - marketscreener.com
Jupiter (JUNS) Quarterly Figures: EPS Lands Above Forecast in the Latest Session; Post-Report Move: Shares Finish 3.67% Down in the Current UpdateDebt Analysis Report - Vinanet
Jupiter Neurosciences, Inc. Common Stock (NASDAQ: JUNS) Stock Price, News & Analysis - Kalkine
JUNS Q4 2025 Earnings: Narrower-Than-Expected Loss Meets 6.16% Surprise but Shares Slide 12.67%Dividend Earnings Report - vinanet.vn
JUNS Q4 2025 Earnings: Narrower Loss Beats Estimates; Shares Slide 12.67%EPS Surprise History - vinanet.vn
JUNS Q4 2025 Earnings: Smaller Loss per Share Beats Estimate, But Shares Slip 12.67%Earnings Call Highlights - vinanet.vn
Jupiter Neurosciences, Inc. Common Stock (NASDAQ: JUNS) Stock Price, News & Analysis - kalkine.ca
Jupiter Neurosciences Inc (JUNS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Finanzdaten der Jupiter Neurosciences Inc-Aktie (JUNS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):